PEOPLE - Neoprobe (US) makes appointment:
This article was originally published in Clinica
Oncology and cardiovascular surgical and diagnostic developer Neoprobe (Dublin, Ohio) has appointed Carl Aschinger to its board of directors. His term runs until 2005, when he will stand for election for another term ending in 2008. Mr Aschinger has been a member of the board of directors of several Columbus, Ohio-based companies.
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.